Combined mechanical circulatory support (Impella + ECMO) in cardiogenic shock caused by fulminant myocarditis

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F25%3A10483402" target="_blank" >RIV/00064165:_____/25:10483402 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/25:10483402
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=XGT3J--VbP" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=XGT3J--VbP</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/ehf2.15001" target="_blank" >10.1002/ehf2.15001</a>

Result language
angličtina
Original language name
Combined mechanical circulatory support (Impella + ECMO) in cardiogenic shock caused by fulminant myocarditis
Original language description
Acute myocarditis affects around 4-14 people per 100 000 each year globally. Approximately 2% to 9% of patients have haemodynamic instability and require inotropic agents or mechanical circulatory support (MCS) devices to facilitate functional recovery. These patients have an approximately 28% rate of mortality or heart transplant at 60 days.1 This case study underscores the key decision points, considerations, and advantages of combining both Impella and veno-arterial extracorporeal membrane oxygenation (VA ECMO) in the treatment of patients suffering from advanced stages of cardiogenic shock (CS) due to fulminant myocarditis.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30221 - Critical care medicine and Emergency medicine

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)